Discontinued — last reported Q3 '23
Business Segments · Restructuring Reserve, Settled without Cash
Prescription Technology Solutions — Restructuring Reserve, Settled without Cash
Year-over-year, this metric declined by 100.0%, from $6.00M to $0.00. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementSegment
CategoryEfficiency
SignalHigher is better
VolatilityVolatile
First reportedQ2 2021
Last reportedQ3 2023
How to read this metric
Higher values indicate that the company is utilizing accounting adjustments or asset write-offs to satisfy restructuring obligations, preserving cash for other operational needs.
Detailed definition
This metric quantifies the portion of restructuring liabilities that are resolved through non-cash means, such as asset...
Peer comparison
Similar to 'non-cash restructuring charges' or 'asset impairments related to restructuring' reported by peers in their segment financial reconciliations.
Metric ID:
mck_segment_prescription_technology_solutions_restructuring_reserve_settled_without_cashHistorical Data
8 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q2 '22 | Q3 '22 | Q4 '22 | Q2 '23 | Q3 '23 | |
|---|---|---|---|---|---|---|---|---|
| Value | $17.00M | $0.00 | $0.00 | $5.00M | $6.00M | $0.00 | $0.00 | $0.00 |
| QoQ Change | — | -100.0% | — | — | +20.0% | -100.0% | — | — |
| YoY Change | — | — | — | -70.6% | — | — | -100.0% | -100.0% |
Range$0.00 – $17.00M
CAGR-100.0%
Avg YoY Growth-90.2%
Median YoY Growth-100.0%
Current Streak3 quarters decline
Similar Metrics at Other Companies
Frequently Asked Questions
- What is McKesson's prescription technology solutions — restructuring reserve, settled without cash?
- McKesson (MCK) reported prescription technology solutions — restructuring reserve, settled without cash of $0.00 in Q3 2023.
- How has McKesson's prescription technology solutions — restructuring reserve, settled without cash changed year-over-year?
- McKesson's prescription technology solutions — restructuring reserve, settled without cash decreased by 100.0% year-over-year, from $6.00M to $0.00.
- What does prescription technology solutions — restructuring reserve, settled without cash mean?
- The portion of restructuring costs settled through non-cash accounting adjustments rather than cash payments.